Planet 13 Holdings (PLNH) Change in Accured Expenses (2022 - 2026)
Planet 13 Holdings (PLNH) reported Change in Accured Expenses of -$1.4 million for Q1 2026, down 1682.93% year-over-year from $86673.0 in Q1 2025, and down 237.01% quarter-over-quarter from -$407100.0 in Q3 2025.
Planet 13 Holdings (PLNH) Change in Accured Expenses (2022 - 2026) Analysis & Trends
Planet 13 Holdings (PLNH) has 5 years of Change in Accured Expenses data on file, last reported at -$1.4 million in Q1 2026.
- Change in Accured Expenses for Q1 2026 came in at -$1.4 million, down 1682.93% year-over-year; the trailing twelve-month figure through Mar 2026 was -$1.4 million (up 27.75% YoY), and the FY2024 annual result was -$2.9 million, down 50.95% from the prior year.
- Change in Accured Expenses declined to -$1.4 million in Q1 2026 per PLNH's latest filing, from -$407100.0 in the prior quarter.
- Over five years, Change in Accured Expenses peaked at $1.9 million in Q4 2022 and troughed at -$3.7 million in Q4 2024.
- A 5-year average of -$347332.9 and a median of -$300374.5 in 2023 frame the typical range for Change in Accured Expenses.
- On a YoY basis, Change in Accured Expenses climbed as much as 194.14% in 2024 and fell as far as 1796.43% in 2024.
- A 5-year view of Change in Accured Expenses shows it stood at $1.9 million in 2022, then plunged by 110.0% to -$193649.0 in 2023, then slumped by 1796.43% to -$3.7 million in 2024, then surged by 88.91% to -$407100.0 in 2025, then sank by 237.01% to -$1.4 million in 2026.
- Business Quant data shows PLNH's Change in Accured Expenses at -$1.4 million in Q1 2026, -$407100.0 in Q3 2025, and $318755.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -144.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -234.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -12.70 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | -14.30 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 4.89 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 10.02 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 23.00 Mn |
| 10 | Planet 13 Holdings | - | - | 9.41 Mn | -1.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.37 Mn |
| Mar 31, 2026 | -1.37 Mn |
| Sep 30, 2025 | -407,100.00 |
| Sep 30, 2025 | -407,100.00 |
| Jun 30, 2025 | 318,755.00 |
| Jun 30, 2025 | 318,755.00 |
| Mar 31, 2025 | 86,673.00 |
| Mar 31, 2025 | 86,673.00 |
| Dec 31, 2024 | -3.67 Mn |
| Dec 31, 2024 | -3.67 Mn |
| Sep 30, 2024 | 632,052.00 |
| Sep 30, 2024 | 632,052.00 |
| Jun 30, 2024 | 1.05 Mn |
| Jun 30, 2024 | 1.05 Mn |
| Mar 31, 2024 | -956,061.00 |
| Mar 31, 2024 | -956,061.00 |
| Dec 31, 2023 | -193,649.00 |
| Dec 31, 2023 | -193,649.00 |
| Sep 30, 2023 | -671,400.00 |
| Sep 30, 2023 | -671,400.00 |